EP EuropaceMolecular BiologyPeer-reviewed journal article
Increased early sodium current causes familial atrial fibrillation and dampens effect of flecainide
Molly O’ReillyiD, Laura C. SommerfeldiD, Christopher O’SheaiD, Sophie Broadway‐StringeriD, S AndaleebiD, Jasmeet Singh ReyatiD, Syeeda Nashitha KabiriD, D StastnyiD, Antonia MalinovaiD, D DelbueiD, Lisa FortmuelleriD, Katja GehmlichiD, Davor PavlovićiD, Boris V. SkryabiniD, Andrew P. HolmesiD, Paulus F. KirchhofiD, Larissa FabritziD
Abstract
(1) AimsAtrial fibrillation (AF) is the most common cardiac arrhythmia. Pathogenic variants in genes encoding ion channels are associated with familial AF. The point mutation M1875T in the SCN5A gene, which encodes the -subunit of the cardiac sodium channel Nav1.5, has been associated with increased atrial excitability and familial AF. (2) MethodsWe designed a new murine model carrying the Scn5a-M1875T mutation enabling us to study the effects of the Nav1.5 mutation in detail in vivo and in vitro using patch clamp and microelectrode recording of atrial cardiomyocytes, optical mapping, ECG, echocardiography, gravimetry, histology and biochemistry. (3) ResultsAtrial cardiomyocytes from newly generated adult Scn5a-M1875T+/- mice showed a selective increase in the early (peak) cardiac sodium current, larger action potential amplitude and a faster peak upstroke velocity. Conduction slowing caused by the sodium channel blocker flecainide was less pronounced in Scn5a-M1875T+/- compared to wildtype atria. Overt hypertrophy or heart failure in Scn5a-M1875T+/- mice could be excluded. (4) ConclusionThe Scn5a-M1875T point mutation causes gain-of-function of the cardiac sodium channel. Our results suggest increased atrial peak sodium current as a potential trigger for increased atrial excitability and thus AF. Whats newO_LIThe point mutation M1875T in the C-terminal domain of the cardiac sodium channel Nav1.5 causes an increase in early peak sodium current in left atria. C_LIO_LIThe observed changes induced by this point mutation suggest an increase in peak sodium current as a cause of familial atrial fibrillation (AF). C_LIO_LIOur findings provide a possible explanation for the variable effectiveness of sodium channel blockers in patients with AF. Carriers of such sodium channel gain-of-function mutations may benefit more from tailored treatments. C_LI Graphical abstract O_FIG_DISPLAY_L [Figure 1] M_FIG_DISPLAY C_FIG_DISPLAY
- Citations
- 18
- FWCI
- 3.13
- Field percentile
- top 7%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Selectivity filter mutation in NaV1.5 promotes ventricular tachycardia
Zoja Selimi, Mikhail Tarasov, … Przemysław Radwański·JACC. Clinical electrophysiologyPeer-reviewed·Feb 6, 2026
- More Severe Loss-of-Function Sodium Channel induced by Compound SCN5A R965C and R1309H Mutants lead to Complex Familial Arrhythmia Syndrome.
Yubi Lin, Jiading Qin, … Xiufang Lin·bioRxiv·Aug 5, 2019
- Nav1.5 regulates intrinsic cardiac neuronal excitability and expands the cellular basis of SCN5A channelopathies
Alice Jean, Hanitriniaina Rabeony, … Aurélien Chatelier·bioRxiv·Oct 7, 2026
- A titin missense variant drives atrial electrical remodeling and is associated with atrial fibrillation
Mahmud Arif Pavel, Hanna Chen, … Dawood Darbar·eLifePeer-reviewed·Jan 22, 2026
- Gene Therapy with the N-terminal Fragment of Nav1.5 for Cardiac Channelopathies: A Novel Transcomplementation Mechanism Potentiating the Cardiac Sodium Current
Marie Gizon, Marine C. Ferrand, … Nathalie Neyroud·bioRxiv·Oct 30, 2024
- Conserved Role of the Large Conductance Calcium-Activated Potassium Channel, KCa1.1, in Sinus Node Function and Arrhythmia Risk
Santiago Balza Pineda, Vesna Nikolova-Krstevski, … Diane Fatkin·Circulation Genomic and Precision MedicinePeer-reviewed·Feb 25, 2021